BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kino H, Nakano M, Kanamori A, Suzuki T, Kaneko Y, Tsuchida C, Tsuchida K, Tominaga K, Sasai T, Yamagishi H, Imai Y, Hiraishi H. Gastric Adenocarcinoma of the Fundic Gland Type after Endoscopic Therapy for Metachronous Gastric Cancer. Intern Med. 2018;57:795-800. [PMID: 29225256 DOI: 10.2169/internalmedicine.9359-17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Chen O, Shao ZY, Qiu X, Zhang GP. Multiple gastric adenocarcinoma of fundic gland type: A case report. World J Clin Cases 2019; 7(18): 2871-2878 [PMID: 31616705 DOI: 10.12998/wjcc.v7.i18.2871] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Mannami T, Tanaka T, Fujiwara N. Gastric adenocarcinoma of fundic gland type with two closely located lesions endoscopically resected en masse. Endoscopy 2021. [PMID: 34496435 DOI: 10.1055/a-1559-2158] [Reference Citation Analysis]
3 Meng X, Yang G, Dong C, Zheng R. Gastric adenocarcinoma of the fundic gland: A review of clinicopathological characteristics, treatment and prognosis. Rare Tumors 2021;13:203636132110601. [DOI: 10.1177/20363613211060171] [Reference Citation Analysis]
4 Ma X, Qiu S, Tang X, Song Q, Wang P, Wang J, Xia Q, Wang Z, Zhao Q, Lu M. TSPAN31 regulates the proliferation, migration, and apoptosis of gastric cancer cells through the METTL1/CCT2 pathway. Translational Oncology 2022;20:101423. [DOI: 10.1016/j.tranon.2022.101423] [Reference Citation Analysis]